News Releases

October 2021

October 21, 2021 10/21/2021 Takeda to Hold Second Quarter FY2021 Earnings Conference Calls

October 8, 2021 10/8/2021 Takeda Sets Terms and Conditions for its 10-Year Yen Denominated Unsecured Senior Bond

October 7, 2021 10/7/2021 FDA Advisory Committee Recommends Use of Investigational Drug Maribavir TAK-620) to Treat Post-Transplant Recipients with Cytomegalovirus CMV Infection and Disease Refractory to Treatment With or Without Resistance

October 5, 2021 10/5/2021 Takeda Provides Update on TAK-994 Clinical Program

September 2021

September 30, 2021 9/30/2021 Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals

September 27, 2021 9/27/2021 Takeda Receives Approval to Manufacture and Market Alofisel®▼ (darvadstrocel) in Japan for Treatment of Complex Perianal Fistulas in Patients with Non-active or Mildly Active Luminal Crohn’s Disease

September 23, 2021 9/23/2021 Takeda Breaks Ground on its First Zero Energy Building in Singapore

September 22, 2021 9/22/2021 Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries

September 16, 2021 9/16/2021 Takeda Continues to Advance Growth Strategy with Sale Of Non-Core Assets in Latin America